| Gene | Gene Full Name | DSI g | DPI g | pLI | Disease | Type | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
HRas proto-oncogene, GTPase | 0.378 | 0.885 | 8.0E-02 |
|
group | 0.300 | None | 0 | 0 | |||||||||||
|
PDZ and LIM domain 3 | 0.547 | 0.769 | 3.0E-07 |
|
group | 0.300 | None | 0 | 0 | |||||||||||
|
KRAS proto-oncogene, GTPase | 0.320 | 0.923 | 7.9E-04 |
|
group | 0.300 | None | 0 | 0 | |||||||||||
|
laminin subunit alpha 4 | 0.682 | 0.577 | 1.4E-24 |
|
group | 0.300 | None | 0 | 0 | |||||||||||
|
B-Raf proto-oncogene, serine/threonine kinase | 0.319 | 0.846 | 1.00 |
|
group | 0.300 | None | 0 | 0 | |||||||||||
|
dystrobrevin alpha | 0.695 | 0.385 | 0.63 |
|
group | 0.300 | None | 0 | 0 | |||||||||||
|
GATA zinc finger domain containing 1 | 0.736 | 0.385 | 0.43 |
|
group | 0.300 | None | 0 | 0 | |||||||||||
|
NRAS proto-oncogene, GTPase | 0.390 | 0.808 | 0.49 |
|
group | 0.300 | None | 0 | 0 | |||||||||||
|
myozenin 2 | 0.716 | 0.308 | 1.6E-03 |
|
group | 0.300 | None | 0 | 0 | |||||||||||
|
mitogen-activated protein kinase kinase 2 | 0.534 | 0.731 | 0.97 |
|
group | 0.300 | None | 0 | 0 | |||||||||||
|
nebulette | 0.650 | 0.692 | 1.8E-36 |
|
group | 0.300 | None | 0 | 0 | |||||||||||
|
titin-cap | 0.682 | 0.538 | 0.19 |
|
group | 0.310 | None | 1.000 | 0 | 0 | 2004 | 2004 | ||||||||
|
junctophilin 2 | 0.736 | 0.154 | 4.5E-05 |
|
group | 0.410 | None | 1.000 | 0 | 0 | 2007 | 2007 | ||||||||
|
DNA polymerase gamma, catalytic subunit | 0.457 | 0.846 | 2.1E-09 |
|
group | 0.420 | None | 1.000 | 0 | 0 | 2004 | 2007 | ||||||||
|
junction plakoglobin | 0.628 | 0.500 | 8.0E-04 |
|
group | 0.410 | None | 1.000 | 0 | 0 | 2011 | 2011 | ||||||||
|
receptor accessory protein 1 | 0.653 | 0.423 | 0.99 |
|
group | 0.300 | strong | 1.000 | 1 | 0 | 2012 | 2012 | ||||||||
|
ATP binding cassette subfamily C member 9 | 0.552 | 0.692 | 9.4E-09 |
|
group | 0.400 | None | 1.000 | 0 | 0 | 2012 | 2012 | ||||||||
|
LIM zinc finger domain containing 2 | 0.751 | 0.308 | 5.1E-05 |
|
group | 0.310 | limited | 1.000 | 1 | 0 | 2015 | 2015 | ||||||||
|
calsequestrin 2 | 0.691 | 0.385 | 1.4E-12 |
|
group | 0.310 | None | 1.000 | 0 | 0 | 2015 | 2015 | ||||||||
|
actin alpha cardiac muscle 1 | 0.610 | 0.538 | 0.74 |
|
group | 0.460 | None | 1.000 | 0 | 0 | 1999 | 2015 | ||||||||
|
sarcoglycan delta | 0.641 | 0.615 | 2.1E-03 |
|
group | 0.580 | None | 0.900 | 0 | 0 | 1997 | 2015 | ||||||||
|
Ras like without CAAX 1 | 0.527 | 0.808 | 0.13 |
|
group | 0.310 | None | 1.000 | 0 | 0 | 2016 | 2016 | ||||||||
|
caveolin 3 | 0.564 | 0.692 | 5.5E-03 |
|
group | 0.350 | None | 1.000 | 0 | 0 | 2003 | 2016 | ||||||||
|
mitogen-activated protein kinase kinase 1 | 0.439 | 0.846 | 0.90 |
|
group | 0.310 | None | 1.000 | 0 | 0 | 2017 | 2017 | ||||||||
|
LIM domain binding 3 | 0.659 | 0.385 | 9.6E-06 |
|
group | 0.410 | None | 1.000 | 0 | 0 | 2017 | 2017 |